Vous êtes ici

XPhyto Therapeutics Corp.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
XPHY
Indice CSE: 
Devise: 

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The Company has research and development operations in North America and Europe and is currently focused on regulatory approval and commercialization of medical products for European markets.

Vous êtes ici

XPhyto Therapeutics Corp. (XPHY)

SEDAR Information

Information d'entreprise

Addresse
Suite 270 - 1820 Fir Street
Vancouver, BC V6J 3B1
Canada
Téléphone
780-818-6422
Courriel
info@xphyto.com
Date d’inscription à la cote
Mercredi, juillet 31, 2019
Agent de transfert
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalisation

Capitalisation: 
64,240,224
Réservé à l'émission: 
23,983,765

Bulletins

30/07/2019

2019-0724 – Nouvelle Inscription - XPhyto Therapeutics Corp. (XPHY)

le 30 juillet/July 2019

The common shares of XPhyto Therapeutics Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Évènements à venir

PDAC_website.png

Virtual PDAC 2021

Lundi, mars 8, 2021 (Jour entier) - Jeudi, mars 11, 2021 (Jour entier)
PDAC_Invite_2021_CSE_Website_740x374_1.jpg

Ridi, Bevi, e Divertiti

Mardi, mars 9, 2021 -
15:00 - 17:00